Managing GLP-1 side effects

Most GLP-1 side effects are predictable, manageable, and time-limited. Here is what helps — and what warrants a message to your clinician.

Last updated: May 4, 2026 Reviewed against: Current obesity-medicine and GLP-1 treatment guidelines Category: Educational

The general pattern

GLP-1 side effects follow a predictable curve: they appear or intensify within the first week of each new dose, peak around days 3–7, and ease over the following 1–2 weeks as your body adapts. Most side effects are gastrointestinal because GLP-1 medications slow gastric emptying.

Nausea

Nausea is the most common side effect. What helps:

Constipation

Diarrhea

Reflux and burping

Fatigue

Fatigue often reflects reduced calorie intake during titration, dehydration, or low protein. Aim for at least 1.2 g of protein per kg of body weight per day, drink enough water, and prioritize sleep. Persistent fatigue beyond the first 2–3 weeks of a new dose deserves a clinician check.

When to call your clinician immediately

Frequently asked questions

How long do side effects usually last?
Most side effects are worst in the first 1–2 weeks of a new dose and ease as your body adapts. If something is still disruptive after 2 weeks, message your clinician.
Should I push through side effects to keep my schedule?
No. Severe or persistent side effects are a reason to slow titration, not push through. Your clinician would rather adjust your plan than have you discontinue.
Can I take anti-nausea medication?
Sometimes — it depends on your medical history. Ask your clinician before adding any new medication, including over-the-counter options.

Ready when you are.

Take a 90-second medical intake. Your clinician reviews it and prescribes only when clinically appropriate.

See treatment plans →

Related reading

References & sources

  1. AACE Clinical Practice Guideline: Comprehensive Medical Care of Patients with Obesity. 2016.
  2. FDA. Wegovy / Ozempic / Zepbound prescribing information.

Editorial standards & medical oversight

This educational content follows WeightlessRx clinical content standards and is reviewed for accuracy against current obesity-medicine and GLP-1 treatment guidelines, including FDA prescribing information, the American Association of Clinical Endocrinology (AACE) obesity guideline, and peer-reviewed clinical literature. Information is educational and is not medical advice. Treatment eligibility is determined only after a U.S.-licensed clinician in our third-party provider network reviews your intake and medical history. Read our full medical review policy →